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Polymorphisms impacting thymic function may decrease peripheral tolerance and 
hasten autoimmune disease. The NF-κB transcription factor subunit, RelB, is essential 
for the development and differentiation of medullary thymic epithelial cells (mTECs): 
RelB-deficient mice have reduced thymic cellularity and markedly fewer mTECs, lack-
ing AIRE. The precise mechanism of this mTEC reduction in the absence of RelB is 
unclear. To address this, we studied mTECs and dendritic cells (DCs), which critically 
regulate negative selection, and thymic regulatory T-cells (tTreg) in RelB−/− mice, which 
have spontaneous multiorgan autoimmune disease. RelB−/− thymi were organized, with 
medullary structures containing AIRE− mTECs, DCs, and CD4+ thymocytes, but fewer 
tTreg. Granulocytes infiltrated the RelB−/− thymic cortex, capsule, and medulla, producing 
inflammatory thymic medullary atrophy, which could be treated by granulocyte depletion 
or RelB+ DC immunotherapy, with concomitant recovery of mTEC and tTreg numbers. 
These data indicate that central tolerance defects may be accelerated by autoimmune 
thymic inflammation where impaired RelB signaling impairs the medullary niche, and may 
be reversible by therapies enhancing peripheral Treg or suppressing inflammation.
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inTrODUcTiOn
Medullary thymic epithelial cells (mTECs) develop from immature mTECs that express the lectin 
UEA-1 and low levels of MHC and costimulatory molecules. Extrinsic signals such as RANKL, 
CD40L, and lymphotoxin-beta promote differentiation of mTECs to mature cells with increased 
MHC, CD80 and AIRE expression (1, 2). The NF-κB transcription factor subunit, RelB, and NF- 
κB-inducing kinase (NIK) upstream of the non-canonical NF-κB pathway, are essential for the deve-
lopment and differentiation of mTECs (3). RelB-deficient mice have reduced thymic cellularity and 
markedly fewer mTECs (4). However, RelB-deficient mice have reduced lifespan due to multiorgan 
autoimmune disease and severe thymic medullary atrophy which limits interpretation of effects 
of RelB on mTEC differentiation or function (5). Thus, the precise role played by RelB in mTEC 
differentiation is unclear.
Furthermore, while mTECs have been shown to support the development of thymic (t)Treg in 
the thymus, the role of RelB in this process is unknown. MHC and CD40/CD154 interactions are 
required together with CD80/86 co-stimulation, thus implicating mature mTECs in thymic regu-
latory T-cells (tTreg) development (6, 7). The role of RelB is particularly relevant, as RelB−/− thymi 
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were shown to lack UEA-1, which is a pan-marker of mTECs 
expressed after their differentiation from bipotent TEC proge-
nitors (4). When Treg development was studied in the context 
of RelB deficiency, fewer tTreg and fewer Foxp3−CD25+CD69+ 
CCR7+CCR9− tTreg precursors developed in wild type mice 
engrafted with RelB−/− than wild type thymi (8). However, RelB−/− 
thymic grafts not only had a marked reduction in ERTR5+ mTECs 
but also demonstrated a severely restricted medullary area.
Despite this reduction in tTreg precursor development in 
RelB−/− thymi, peripheral Treg (pTreg) are present at increased 
frequency in the spleen and disease-affected tissues of RelB−/− 
mice. RelB−/− Treg are functionally defective due to deficient 
dendritic cell (DC) expression of MHC class II and costimulatory 
molecules required for effective TCR signaling (9). Adoptively 
transferred RelB+ DCs are able to license pTreg to suppress 
autoreactive T  cells and inflammatory disease, demonstrating 
that pTreg developing in RelB−/− mice are functional when appro-
priately signaled. Furthermore, functional pTreg are essential for 
dominant tolerance in this model (9). Although these results 
demonstrate that pTreg develop through RelB-independent 
mechanisms, the relationship between tTreg development and 
RelB-deficient thymic antigen-presenting cells (APCs) remains 
unclear.
Medullary dendritic cells (DCs) interwoven with mTECs 
also contribute to tTreg development (10). mTECs can provide 
signals to DCs such as XCL1, which localizes DCs to the medulla. 
XCL1-deficient mice have reduced tTregs (11). In addition, 
inhibition of Delta-like ligand-4/Notch signaling enables DN1 
T cell progenitors to differentiate into DCs to expand tTregs, and 
mTECs expressing NIK are required for expression of costimu-
latory molecules by thymic DCs (3, 12). These results indicate 
that expansion of mature DCs within the thymus correlates with 
increased tTreg development. However whether this is directly 
due to DCs or results from mTECs promoting tTreg develop-
ment and recruiting DCs to the thymus is currently unknown. 
Furthermore, the relative impact on tTreg development of mTEC 
and DC RelB expression has not been determined. In turn, ext-
rinsic signals from activated T cells are required to activate RelB 
expression for the development of mature mTECs. Therefore, we 
studied the impact of RelB deficiency on medullary development, 
mTECs, DCs, and tTreg cell generation in the thymus.
MaTerials anD MeThODs
Mice
All mice were maintained in specific pathogen-free conditions. 
Mice homozygous for an insertional mutation in the RelB gene 
(designated RelB−/−), on a C57BL/6 background, were generated 
as described (5) and used for experiments at 4–9 weeks of age. 
RelB+/− mice displaying neither pathology nor immune dysfunc-
tion, or C57BL/6 (RelB+/+) were used as controls. RelB−/− radia-
tion chimeras [bone marrow chimeras (BMC)] were generated 
by transferring bone marrow from RelB−/− or RelB+/− into lethally 
irradiated C57BL/6 hosts (Animal Resource Centre, Perth, WA, 
Australia). Mice were used after at least 8 weeks of reconstitution. 
All experiments were approved by the University of Queensland 
Animal Ethics committee. All mice were housed in a pathogen-
free environment.
Treatment of relB−/− Mice
CD11c+ DCs were isolated from disaggregated, collagenase-
treated RelB+/− spleens using CD11c-conjugated immunoma-
gnetic beads (Miltenyi Biotec, Bergisch Gladbach, Germany). Five 
million splenic RelB+/−CD11c+ DCs were injected into RelB−/− 
recipients intravenously. For granulocyte depletion, RelB−/− mice 
were administered 500  µg of anti-Ly6G (clone 1A8, BioXcell) 
antibody twice weekly for 4 weeks. For expansion of thymic DC, 
RelB−/− or RelB+/+ mice were administered Progenipoeitin-1 
(Pharmacia, St. Louis, MO, USA), subcutaneously 20 μg/animal 
per day for 10 days.
analysis of mTecs
Individual collagenase-treated, disaggregated thymi were stained 
for MHC class II, Ly51, and CD45.1 (A20) and analyzed by flow 
cytometry. mTECs were CD45.1−Ly51−MHCII+, and cTECs were 
CD45.1−Ly51+MHCII+.
analysis of Thymic Treg
Individual collagenase-treated, disaggregated thymi were stained 
for CD4 (GK1.1), CD8 and Foxp3 (FJK-16s) together with other 
markers including CD44 (IM78.1), CD62L (MEL14), CD69 
(H1.2F3), CD103 (2E7), GITR (DTA-1), or Vβ panel of antibo-
dies (BD Pharmingen).
histology
Formalin-fixed thymi from RelB−/− mice were sectioned and 
stained with hematoxylin and eosin.
immunofluorescence and confocal 
Microscopy
Tissues were harvested and immersed in OCT freezing medium 
and 10  µm sections prepared using a microtome. Sections 
were fixed in ice cold acetone and blocked with 5% BSA and 
0.1% Tween-20, then were incubated with antibody in bloc-
king buffer, washed and mounted with fluorescent mounting 
medium. They were visualized on an LSM-510-meta confocal 
microscope (Carl Zeiss Micro Imaging GmBH, Gottingen, 
Germany). Antibody clones include the following: MTS10, RelB 
(C-20), CD11c-APC (N418), CD4-PE (RM4-5), CD8-APC 
(53-6.7), Foxp3-Alexa-488 (FJK-16s), F480-Alexa-488 (BM8), 
CD11b-PE (Clone M1/70), and Gr1-APC (RB6-8C5). DAPI 
identified cell nuclei (13–15).
statistical analysis
Unpaired, two-tailed, Student’s t tests, ∝  =  0.05, assessed 
whether the means of two normally distributed groups dif-
fered significantly. Mann–Whitney test (unpaired) was used for 
non-normally distributed means or for sample sizes <10. One-
way ANOVA analysis with Bonferroni’s multiple comparison 
post-test compared multiple means. Significance is indicated as 
*p < 0.05, **p < 0.005, and ***p < 0.001. All error bars represent 
SEM.
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resUlTs
Preservation of the Medullary niche  
for tTreg Development but Biased  
Tcr repertoire in relB−/− Mice  
lacking aire+ mTecs
RelB is required for development of AIRE+ mTECs. RelB−/− mice 
also have impaired negative selection, and T-cell-dependent mul-
tiorgan autoimmune disease (4, 16–18). RelB−/− thymi had fewer 
total TECs including cTECs and mTECs, and fewer thymic DCs 
than in wild type (RelB+/−) mice (Figures 1A–C). The numbers 
of mTECs and DCs were correlated, with a Spearman coefficient 
of 0.9 (Figure  1D). As previously reported, RelB−/− mice had 
reduced medullary size compared with RelB+/− thymi, and AIRE 
staining was not detected in RelB−/− medulla (Figures  1E,F; 
Figure S1 in Supplementary Material).
Consistent with the small size of the thymus, the numbers of 
CD4+ SP thymocytes and tTreg developing in RelB−/− thymi were 
reduced (Figures 2A,B). mTEC numbers correlated with tTreg 
numbers but not proportion (Figures  2C,D). By contrast, the 
numbers of CD4+ SP thymocytes and tTreg isolated from thymi 
from RelB−/− → RelB+/− BMC and control RelB+/− → RelB+/− BMC 
were equivalent (Figures 2A,B). The BMC data indicate that RelB 
expression in non-mTECs, including DCs, did not influence 
Treg development. However, RelB−/− tTreg had reduced com-
petitive fitness compared with RelB+/− Treg in 50:50 mixed BM 
chimera mice, indicating a minor cell-intrinsic role for RelB in 
tTreg development (Figures 2E–G; Figure S2 in Supplementary 
Material). Although fewer, tTreg developing in the absence of 
RelB expressed similar levels of CD44, GITR, CD69, CD62L, and 
CD103 to control mice (Figure 2H). SP and Foxp3+ thymocytes 
could be identified in the medulla of RelB−/− mice (Figure  2I; 
Figure S3 in Supplementary Material). Cellular analysis of thymic 
tissue from RelB+/− mice demonstrated a similar thymic medullary 
architectural organization with RelB expression and resident DCs 
within medullary regions (Figure 1F). RelB deficiency not only 
reduced tTreg development but also biased Vβ usage in Foxp3+ 
T cells in the thymus with expanded Vβ4, Vβ8.1, and Vβ14 TCR 
(Figure  2J). Together, these data indicate that although tTreg 
development is reduced when mTECs lack RelB, the medullary 
niche for tTreg development is preserved in RelB−/− mice lacking 
AIRE+ mTECs and tTreg are phenotypically indistinguishable 
from RelB+/− tTreg. However, they have a TCR bias consistent 
with expanded autoreactive clones (19–22).
expansion of Thymic Dcs and of tTreg are 
relB Dependent
The correlation between DCs, mTECs and tTreg and the chemokine 
downregulation in RelB−/− thymus suggests that mTEC prolife-
ration/survival might provide an appropriate environment to 
support DC seeding of the medulla and/or that expansion of DCs 
may be required to increase thymic mTEC and tTreg numbers and 
medullary size. We therefore tested whether the medulla could 
be expanded by inducing intra-thymic DC proliferation with 
Progenipoeitin-1 (ProGP-1: recombinant G-CSF and flt3-L) (23) 
administered to mice for 10 days. After ProGP-1, DCs expanded in 
RelB+/+ but not RelB−/− thymus (Figure 3A). Consistent with our 
hypothesis, the number of mTECs and tTregs also increased only 
in RelB+/+ thymus (Figures 3B,C). There was no similar response 
to ProGP-1 in RelB−/− thymus. Since DCs and tTreg numbers are 
not reduced in RelB−/− → RelB+/− relative to RelB+/− → RelB+/− chi-
meras these data indicate that mTEC RelB expression is required 
for mTEC/DC expansion and increased Treg output.
Thymic inflammation associated  
With atrophy in relB−/− Mice
We noted that RelB−/− thymi were not only small but also were 
infiltrated in the thymic capsular sinus by polymorphonuclear 
leukocytes, as identified by hematoxylin and eosin staining 
(Figure  4A), suggesting the possibility of inflammatory tissue 
damage. The percentage of CD11b+ granulocytes was increased 
in RelB−/− thymi compared with RelB+/− thymi (Figure  4B). 
The inflammatory CD11b+Ly6c/g+ granulocytic infiltrate 
accumulated around the cortex and adjacent to the capsule of 
RelB−/− thymus but not RelB+/+ thymus (Figure  4C; Figure S4 
in Supplementary Material). CD11b+ cells accumulating in the 
medulla were F480+, including Ly6c/g− eosinophils and Ly6c/g+ 
neutrophils (Figure 4D). Thus thymi of RelB−/− mice are affected 
by severe inflammatory cell infiltration.
granulocyte Depletion Preserves  
Thymic Function and enhances  
tTreg Development in relB−/− Mice
To determine whether infiltrating granulocytes suppressed thymic 
function, we treated 6- to 8-week-old RelB−/− mice twice weekly 
for 4  weeks with anti-Ly6g mAb to deplete granulocytes. Flow 
cytometric analysis of peripheral blood demonstrated variable 
longitudinal reduction of Ly6g+ granulocytes (Figure  5A). In 
spleen, the proportion of CD11b+ granulocytes was reduced and 
the proportion of B  cells increased after 4  weeks (Figure  5B; 
Figure S5 in Supplementary Material). Comparison of thymi from 
age-matched RelB−/− mice with and without 4-week granulocyte 
depletion demonstrated an overall increase in thymocytes, mTECs, 
and thymic DCs, consistent with preservation of thymic medul-
lary size in mice treated with anti-Ly6g mAb (Figures  5C,D). 
Furthermore, the number of granulocytes in the thymus cor-
related negatively with the number of mTECs in individual 
RelB−/− mice (Figure 5E). The larger medullary niche afforded by 
the increased number of mTECs upon granulocyte depletion was 
associated with increased numbers of SP CD4+ and CD8+ T cells, 
including SP CD4+Foxp3+ tTreg (Figures 5F,G). These data dem-
onstrate inflammatory, granulocyte-associated thymic atrophy 
in RelB−/− mice, and that depletion of granulocytes attenuates 
medullary atrophy and improves thymic T cell output including 
tTreg. Together, these data indicate that granulocytes infiltrating 
the thymus of RelB−/− mice accelerate thymic atrophy.
Transfer of relB+ Dcs Preserves  
Thymic structure due to suppression of 
autoimmune inflammation in the Thymus
A T cell-dependent, B cell-independent autoimmune inflamma-
tory granulocytic infiltrate affects multiple organs in RelB−/− mice 
FigUre 1 | RelB deficiency reduces medullary thymic epithelial cell (mTEC) and dendritic cell (DC) numbers in thymus. (a) Reduced TECs, including cTECs 
[CD45−MHCII+ (IA-E) EPCAM+Ly51+] and mTECs (CD45−MHCII+EPCAM+Ly51−) in RelB−/− thymi. (B) mTECs (MHCII+, Ly51−) and cTEC (MHCII+, Ly51+) and  
(c) MHCII+CD11c+ DC numbers in thymi from RelB−/− and RelB+/− mice; **p ≤ 0.01 (unpaired Student’s two-tailed t test). (D) Analysis of individual mice showing 
correlation of mTEC number and DC number; Spearman method. (e) Representative immunofluorescence staining of frozen thymic section from RelB−/− mouse. 
MTS10+ mTECs (green) and CD11c+ DC (blue) are AIRE negative (red). (F) Representative immunofluorescence staining of frozen thymic section from C57BL/6 
mice. Both CD11c+ DCs (blue) and MTS10+ mTECs (green) are RelB+ (red). RelB expression is highest in the corticomedullary junction (cmj). Medulla (m) and the 
cortex (c) are shown.
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FigUre 2 | RelB deficiency reduces Treg numbers in thymus. SP CD4+ (a) and Foxp3+CD4+ (B) cell numbers in thymi from RelB+/−, RelB−/−, RelB+/− bone marrow 
chimeras (BMC) and RelB−/− BMC mice; **p ≤ 0.01 (unpaired Student’s two-tailed t test). (c) Analysis of individual mice showing correlation between medullary 
thymic epithelial cell (mTEC) number and Treg number; Spearman method. (D) Analysis of individual mice showing no change in Treg proportions relative to mTEC 
numbers. (e) Thymic Treg development in mixed RelB−/−/RelB+/− (50:50) → RelB+/− BMC: flow cytometry analysis of a representative BMC mouse showing 
proportions of RelB+/− Treg (CD45.1) and RelB−/− Treg (CD45.2) in SP CD4+ (F) and SP CD8+ (g) donor cells. (h) Percentage of thymic Treg from RelB+/− and 
RelB−/− mice expressing surface markers as determined by flow cytometry. (i) Thymic frozen sections from RelB−/− mice showing CD11c+ DCs (blue) and Foxp3+ 
Treg (green) in the medulla and normal localization of SP CD4+ T cells (red). (J) Proportion of Vβ TCR in SP CD4+Foxp3− and CD4+Foxp3+ T cells in thymus of 
RelB+/− and RelB−/− mice as determined by flow cytometry.
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FigUre 3 | RelB expression is required for medullary thymic epithelial cell (mTEC)/dendritic cell (DC) expansion and increased Treg output in response to ProGP-1. 
Thymi from mice treated with ProGP-1 were harvested, collagenase digested, and analyzed by flow cytometry to determine the number of MHCII+CD11c+ DC (a), 
mTEC (B), and SP CD4+Foxp3+ Treg (c); *p ≤ 0.05, **p ≤ 0.01, and ***p ≤ 0.001 (unpaired Student’s two-tailed t test).
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(9, 24). Furthermore, adoptive transfer of low numbers of RelB-
sufficient DCs to RelB−/− mice induced dominant Treg-mediated 
suppression of autoimmune disease, as measured by weight gain, 
improved clinical scores, and reduced granulocyte infiltration of 
the spleen (9). Therefore, we examined whether thymic medul-
lary atrophy in RelB−/− mice could be prevented by adoptive 
transfer of DCs, through dominant tolerance of autoimmune 
disease. In RelB−/− mice treated with RelB+/− DCs, the numbers of 
infiltrating CD11b+Gr1+ myeloid cells decreased in the thymus, 
relative to DCs (Figure  6A). The absolute numbers of mTECs 
and DCs in the medulla increased with DC adoptive therapy 
(Figure 6B), and the development of SP T cells, including tTreg, 
increased (Figures 6C,D). These data strongly suggest that the 
thymic inflammation and accelerated atrophy in RelB−/− mice 
is autoimmune. Furthermore, thymic DCs, mTECs, and tTreg 
output can be preserved by RelB+/− DC immunotherapy, which 
controls granulocytic inflammation in RelB−/− mice. Thus, the 
medullary niche for mTEC, DC, and tTreg survival and expan-
sion can be preserved in RelB−/− thymus either by depletion of 
granulocytes or suppression of autoimmune disease using DC 
immunotherapy.
DiscUssiOn
Medullary TECs and DCs support the development of tTreg in 
the thymus. Several studies have analyzed the role of mTECs in 
tTreg development in RelB-deficient thymus because of the severe 
reduction in mTECs. However, the severe thymic medullary 
atrophy and multiorgan autoimmune disease in RelB−/− mice 
(5) limits interpretation of effects of RelB on tTreg development. 
Unexpectedly, considering the reduction in proportion and num-
bers of tTreg, thymi isolated from RelB−/− mice were appropriately 
organized, with medullary structures containing DCs, SP CD4+ 
cells and Foxp3+ tTreg. RelB−/− mTECs were AIRE−. RelB−/− tTreg 
were phenotypically similar to RelB+/− tTreg. However, relative 
to control mice, the numbers of tTreg were reduced in RelB−/− 
mice and unchanged in RelB−/− BMC. Granulocytes infiltrated 
the RelB−/− thymic cortex, capsule, and the medulla, associated 
with an enrichment in genes mediating myeloid cell chemotaxis. 
Importantly, RelB−/− mice had profound granulocyte-induced 
inflammatory thymic medullary atrophy, which could be treated 
by granulocyte depletion or RelB+ DC immunotherapy, with 
concomitant recovery of tTreg numbers. While the exact mecha-
nism by which the infiltrating granulocytes promote this thymic 
atrophy is unknown, RelB is known to repress Il1b and granulo-
cyte extracellular traps could act as a platform for IL-1 activation 
(25, 26). These data demonstrate that RelB deficiency profoundly 
affects tTreg development due to reduced size of the medullary 
niche, as a result of inflammatory thymic medullary atrophy. This 
conclusion has important implications for autoimmune diseases 
where polymorphisms in genes such as Traf6, Relb, and Rel 
reduce expression and transcriptional activity of RelB in thymus 
(27, 28), including loss of function. Rare RelB mutations have 
indeed been identified in humans, with similar reduction in 
thymic size, disorganized corticomedullary architecture, altered 
thymic T  cell maturation, reduced T  cell output, and skewed 
T cell repertoire (29).
We show here that accelerated autoimmunity was a further 
consequence of this medullary atrophy, including lymphopenia 
due to reduced output of CD4+ SP cells and decreased TCR 
diversity skewed toward Vβ4, very likely due to limited periph-
eral tissue antigen expression by mTECs within the niche, and 
lack of AIRE expression (30–33). In consequence, self-reactive 
peripheral Teff and Treg expansion and organ-specific inflam-
matory disease were evident (9). With respect to the role of 
thymic DCs in tTreg development, the normal output of tTreg 
in RelB−/− BMC demonstrates that if mTECs and the medullary 
niche are intact then RelB expression by DCs is not required 
for normal tTreg development. Even the failure to differentiate 
mature mTECs in the absence of RelB itself had a minor impact 
on tTreg development, since tTreg output increased with two 
strategies to reduce granulocytic infiltration of the thymus. 
Rather, the autoimmune consequences of the defect in negative 
selection, the functional deficiency of pTreg and granulocytic 
inflammation, together, reduced tTreg output. This interpreta-
tion is consistent with experimental data demonstrating that 
tTreg development is impaired in RelB−/− thymic grafts into 
wt mice, where the medulla was atrophied (8). Furthermore, 
FigUre 4 | Thymic inflammation in RelB−/− mice. Hematoxylin and eosin staining of RelB−/− (a) and RelB+/− (B) thymi. Arrows in panel (a) show granulocytes.  
(c) Thymi from RelB−/− and RelB+/− mice were collagenase-digested and disaggregated; cells were counted and stained for Ly6c/g, CD11b, and F480, then 
analyzed by flow cytometry; *p ≤ 0.05 (unpaired Student’s two-tailed t test). (D) Immunofluorescent staining of frozen thymic sections obtained from RelB−/−  
mice for CD11b, F4/80, and Ly6c/g. CD11b+F480+ cells are seen in the medulla (m) and cortex, particularly adjacent to the capsule (sub-capsular inflammation 
marked by rectangle).
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in a more direct experiment, mice with conditional deletion of 
Traf6 (upstream of RelB) in mTECs had a similar reduction in 
mTEC differentiation, reduction in AIRE+ mTECs, and reduced 
medullary size without thymic inflammation. This reduction 
in medullary size was associated with a 50% reduction in tTreg 
output. Organ-specific autoimmune disease in these mice devel-
oped much later than in RelB−/− mice, as peripheral tolerance 
and pTreg function was shown to be normal.
AIRE increases expression of peripheral antigens by mTECs, 
including insulin, salivary protein-1 and fatty acid binding pro-
tein. AIRE also promotes apoptosis of mTECs, facilitating cross 
presentation of antigen to DCs (34). AIRE−/− mice differ from 
RelB−/− mice, in that they retain mature mTECs and they can 
express non-AIRE encoded peripheral tissue antigens, such as 
C-reactive protein and GAD67. AIRE−/− mice also have reduced 
medullary accumulation of thymic DCs that, together with 
mTECs, promote tTreg development (10, 11). AIRE−/− mTECs 
still attract DCs to medullary regions independently of AIRE 
and AIRE-induced chemokines, such as XCL1, CCL19, CCL21, 
and CCL25 (11), some of which were decreased in RelB−/− mice. 
However, medullary DC accumulation was reduced when 
mTECs were reduced. The reduced thymic medullary area for 
negative selection and Treg development, and the reduction in 
mTEC AIRE are together likely to explain the organ-specific 
autoimmune disease in RelB−/− mice. The increased severity of 
autoimmune disease in RelB−/− relative to AIRE−/− mice is also 
FigUre 5 | Depletion of neutrophils prevents thymic atrophy in RelB−/− mice. RelB−/− mice (6–8 weeks of age) were treated twice weekly for 4 weeks with 
depleting anti-Ly6G antibody. (a) Proportion of peripheral blood neutrophils (CD11b+, Ly6c−, and Ly6G+) as assessed by flow cytometry during depletion. (B) 
Proportion of immune cells in the spleen after 4 weeks of neutrophil depletion; *p ≤ 0.05 and **p ≤ 0.01 (unpaired Student’s two-tailed t test). Collagenase-
digested thymi from anti-Ly6G-treated RelB−/− mice or age-matched RelB−/− mice were analyzed by flow cytometry to determine the number of thymocytes (c), 
medullary thymic epithelial cells (mTECs), cTEC, MHCII+CD11c+ dendritic cell (DC) (D), CD4 and CD8 SP cells (g), and SP CD4+Foxp3+ Treg (F); *p ≤ 0.05 and 
**p ≤ 0.01 (unpaired Student’s two-tailed t test). (e) Analysis of individual mice showing correlation of mTEC number with number of thymic granulocytes; 
Spearman method.
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consistent with the additional Treg dysfunction in RelB−/− mice. 
In AIRE−/− mice pTreg function is normal and TCR sequencing 
of Treg and Teff clones from organs of TCR-mini transgenic mice 
crossed with AIRE−/− mice showed that Treg TCR diversity is 
maintained independent of AIRE, with little overlap in the TCR 
repertoire of Teff and Treg clones isolated from disease-affected 
salivary glands (35).
ProGP-1 and FLT3L have been shown to expand peripheral 
CD11c+CD8+MHCIIhi DCs in mice (23). We show that proGP-1 
also expands thymic DCs, with concomitant increases in mTECs 
and tTreg. Thymic renewal driven by proGP-1 was dependent on 
RelB, potentially due to a requirement for RelB expression for 
development of bipotent TEC progenitors (17). While FLT3L 
administration expanded peripheral DCs and pTreg numbers, 
FigUre 6 | Transfer of RelB+ dendritic cells (DCs) preserves thymic structure. RelB−/− mice were adoptively transferred with 5 × 106 RelB+/− DCs. (a) Thymi from 
RelB+/− (8–10 weeks), untreated RelB−/− (8–10 weeks), or RelB+/− DC-treated RelB−/− mice (8–10 weeks of age treated for 2 weeks) were harvested, collagenase 
digested, and analyzed by flow cytometry to determine the ratio of DCs (MHCII+CD11c+) to granulocytes (CD11b+CD11clo); **p < 0.01 (one-way ANOVA followed  
by Bonferroni’s post hoc test). Thymi from untreated RelB−/− (8–10 weeks) or DC-treated RelB−/− mice (8–10 weeks of age treated for 2 weeks) were compared for 
numbers of medullary thymic epithelial cell (mTEC), cTEC, DC (B), SP CD4, SP CD8, DN, DP (c), and SP CD4+Foxp3+ Treg (D); *p ≤ 0.05, **p ≤ 0.01, and 
***p ≤ 0.001 (unpaired Student’s two-tailed t test).
9
O’Sullivan et al. Accelerated Thymic Atrophy in Autoimmunity
Frontiers in Immunology | www.frontiersin.org May 2018 | Volume 9 | Article 1092
this was not accompanied by increases in thymic Treg (36). 
Furthermore, G-CSF had no impact on thymocyte progenitor 
activity in rats (37). Our data therefore implicate G-CSF in the 
expansion of mTEC progenitors, but only when associated with 
FLT3L-mediated DC expansion, and suggest the hypothesis that 
expansion of the appropriate DC subset in the thymus can signal 
proliferation of mTECs from progenitors (38), providing a niche 
for tTreg development.
In summary, genetically mediated central tolerance defects 
may be accelerated by thymic inflammation where polymor-
phisms impair mTEC development. Given that thymic inflam-
mation may be triggered by infection, this has important 
implications for the development of childhood autoimmune 
diseases associated with neutrophilia and eosinophilia (39). 
Furthermore, accelerated thymic atrophy may be reversible at 
least in part by therapies that enhance pTreg function and/or that 
limit innate inflammatory cell-mediated thymic inflammation.
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